好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Fluoroscopy Guided Block in Nervus Intermedius Neuralgia
Pain
P1 - Poster Session 1 (8:00 AM-9:00 AM)
12-007
This case report highlights a rarely reported successful treatment of nervus intermedius neuralgia (NIN) with peripheral nerve block under fluoroscopic guidance.

Idiopathic NIN (aka geniculate neuralgia) is a rare cranial neuralgia that presents as severe paroxysmal pain in the ear canal and auricle. Treatment options are limited.

A 29 year old woman presented with an acute flare of severe paroxysmal intermittent 1-2 second long attacks located in the right ear canal and posterior to the ear. Prior similar attacks could last for days. Physical exam revealed pain with palpation of the posterior wall of the ear canal with Q-tip. MRI of the brain with and without gadolinium and cervical spine was unremarkable. She previously failed to respond to a trial of gabapentin. A diagnosis of NIN was considered. During an acute attack she underwent fluoroscopy guided anesthetic block of the geniculate branch of the facial nerve with lidocaine and dexamethasone.
After the procedure the patient reported only three mild, brief paroxysmal episodes of pain in a 24 hour period, and afterwards returned to a baseline without any pain. She has not had another flair for three months since the block.

NIN is a painful cranial neuralgia that is challenging to treat. Due to its rarity, there is inconclusive evidence for treatment guidelines. Current treatment includes carbamazepine, gabapentin, baclofen or neurosurgical procedures if medication fails. There is a paucity of reported cases demonstrating successful response to peripheral nerve blocks in NIN, and two reported cases that report unsuccessful response to block nerve block. We describe our technique for fluoroscopy guided nervus intermedius (geniculate nerve) block for the treatment of NIN and highlights this interventional approach as a treatment option which can be utilized by neurologists or pain physicians for this debilitating condition in which current treatment is limited.

Authors/Disclosures
MerryJean Losso, MD (Northwestern Medicine)
PRESENTER
Dr. Losso has nothing to disclose.
Tigran Kesayan, MD (VUMC Pain Medicine and Neurology) Dr. Kesayan has nothing to disclose.